IBM

221.29

0.13% -0.29

시간 외 거래: 221.75 0.46 +0.21%

International Business Machines Corp (IBM)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측 주식 분할 배당 이력

전일 마감가:

$221.58

열려 있는:

$222.71

하루 거래량:

3.93M

Relative Volume:

0.49

시가총액:

$208.48B

수익:

$68.91B

순이익/손실:

$10.73B

주가수익비율:

19.57

EPS:

11.3093

순현금흐름:

$12.26B

1주 성능:

+0.59%

1개월 성능:

-5.79%

6개월 성능:

-10.31%

1년 성능:

-23.54%

1일 변동 폭

$221.00

$224.51

1주일 범위

$218.60

$234.27

52주 변동 폭

$199.19

$332.46

International Business Machines Corp Stock (IBM) Company Profile

명칭

International Business Machines Corp

부문

Technology (775)

산업

Information Technology Services (74)

전화

(914) 499-1900

주소

1 NEW ORCHARD ROAD, ARMONK, NY

직원

287,000

트위터

@IBMAsiaPacific

다음 수익 날짜

2026-10-21

최신 SEC 제출 서류

IBM's Discussions on Twitter

Compare IBM vs ACN, INFY, CTSH, FISV

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
IBM International Business Machines Corp	221.29	209.76B	68.91B	10.73B	12.26B	11.31
ACN Accenture Plc	193.40	121.72B	73.10B	7.94B	12.58B	12.52
INFY Infosys Ltd Adr	10.55	42.53B	20.21B	3.33B	3.87B	0.8084
CTSH Cognizant Technology Solutions Corp	57.22	25.82B	21.41B	2.23B	2.47B	4.6058
FISV Fiserv Inc	45.48	24.72B	21.09B	3.22B	4.17B	5.8948

International Business Machines Corp Stock (IBM) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2026-07-22	개시	Robert W. Baird	Neutral
2026-07-15	다운그레이드	Oppenheimer	Outperform → Perform
2026-07-14	다운그레이드	HSBC Securities	Hold → Reduce
2026-07-10	개시	Susquehanna	Neutral
2026-06-23	업그레이드	JP Morgan	Neutral → Overweight
2026-06-01	개시	Barclays	Overweight
2026-04-28	업그레이드	HSBC Securities	Reduce → Hold
2026-04-24	업그레이드	DZ Bank	Hold → Buy
2026-04-10	개시	Citigroup	Buy
2026-02-25	업그레이드	UBS	Sell → Neutral
2026-02-18	다운그레이드	Erste Group	Buy → Hold
2026-01-20	재확인	Evercore ISI	Outperform
2026-01-05	업그레이드	Jefferies	Hold → Buy
2025-12-05	업그레이드	Erste Group	Hold → Buy
2025-11-21	개시	Oppenheimer	Outperform
2025-09-16	개시	Bernstein	Mkt Perform
2025-08-14	다운그레이드	Erste Group	Buy → Hold
2025-02-11	개시	Oppenheimer	Outperform
2025-02-03	재개	Wedbush	Outperform
2024-10-02	다운그레이드	DZ Bank	Buy → Hold
2024-06-24	개시	Goldman	Buy
2024-05-02	개시	Exane BNP Paribas	Underperform
2024-01-19	업그레이드	Evercore ISI	In-line → Outperform
2024-01-05	개시	Jefferies	Hold
2024-01-05	다운그레이드	Societe Generale	Hold → Sell
2023-12-05	재확인	BofA Securities	Buy
2023-09-20	개시	RBC Capital Mkts	Outperform
2023-07-17	재확인	BMO Capital Markets	Market Perform
2023-07-07	개시	JP Morgan	Neutral
2023-04-20	재확인	BMO Capital Markets	Market Perform
2023-04-20	재확인	Evercore ISI	In-line
2023-04-20	재확인	Morgan Stanley	Equal-Weight
2023-04-20	재확인	Stifel	Buy
2023-02-06	다운그레이드	Edward Jones	Buy → Hold
2023-01-24	업그레이드	MoffettNathanson	Underperform → Market Perform
2023-01-19	업그레이드	MoffettNathanson	Underperform → Market Perform
2023-01-18	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2022-10-20	재확인	Credit Suisse	Outperform
2022-10-20	재확인	Evercore ISI	In-line
2022-10-20	재확인	UBS	Sell
2022-10-12	재확인	Credit Suisse	Outperform
2022-08-17	재개	Credit Suisse	Outperform
2022-04-14	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2022-01-11	다운그레이드	UBS	Neutral → Sell
2022-01-10	개시	Goldman	Neutral
2021-12-15	재확인	Stifel	Buy
2021-12-02	재개	Evercore ISI	In-line
2021-10-29	재개	Credit Suisse	Outperform
2021-10-05	재확인	Credit Suisse	Outperform
2021-10-01	개시	Jefferies	Buy
2021-07-20	업그레이드	Societe Generale	Sell → Hold
2020-09-23	재개	UBS	Neutral
2020-07-22	업그레이드	Argus	Hold → Buy
2020-04-21	재확인	Morgan Stanley	Equal-Weight
2020-02-03	업그레이드	Edward Jones	Hold → Buy
2020-01-17	다운그레이드	Morgan Stanley	Overweight → Equal-Weight
2020-01-13	다운그레이드	Evercore ISI	Outperform → In-line
2019-10-21	다운그레이드	UBS	Buy → Neutral
2019-10-17	재확인	BMO Capital Markets	Market Perform
2019-10-17	재확인	Nomura	Buy
2019-10-17	재확인	Wedbush	Neutral
2019-10-17	재확인	Wells Fargo	Market Perform
2019-08-01	재개	Morgan Stanley	Overweight
2019-07-18	재개	JP Morgan	Neutral
2019-06-06	개시	Evercore ISI	Outperform
2019-04-11	개시	Credit Suisse	Outperform
2019-01-23	재확인	Citigroup	Buy
2019-01-23	재확인	RBC Capital Mkts	Outperform
2019-01-23	재확인	Wells Fargo	Market Perform
2018-10-18	다운그레이드	Argus	Buy → Hold
2018-10-04	개시	MoffettNathanson	Sell

모두보기

International Business Machines Corp 주식(IBM)의 최신 뉴스

Oct 01, 2026

IBM (IBM) director Michelle J. Howard acquires fee shares, bringing her balance to 17,050. - Stock Titan

Oct 01, 2026

A director award brings Andrew N. Liveris’s IBM (IBM) fee-share holdings to 45,262. - Stock Titan

Oct 01, 2026

IBM (IBM) director Frederick William McNabb III acquires 415 shares deferred until retirement. - Stock Titan

Oct 01, 2026

IBM (IBM) Shares Fall 23% YTD Amid Mixed Analyst Views Ahead of Q3 Earnings - GuruFocus

Oct 01, 2026

IBM (IBM) director Farr acquires 268 deferred fee shares payable at retirement. - Stock Titan

Oct 01, 2026

IBM (IBM) director acquires 444 fee shares payable in stock or cash after retirement. - Stock Titan

Oct 01, 2026

IBM (IBM) director acquires 415 fee shares payable in stock or cash after retirement. - Stock Titan

Oct 01, 2026

Accenture Earnings Lift Software and IT Services Stocks: Cognizant, IBM, Wipro Rise on Thursday - Benzinga

Oct 01, 2026

Why Is International Business Machines (NYSE:IBM) Suddenly a Must-Watch Bluechip Stocks Stock Today? - Kalkine Media

Oct 01, 2026

Hedera Jumped 27% on an IBM Cloud Deal and Gave Back 16% the Next Day. HBAR vs XRP: Which Enterprise Coin Is the Better Buy? - Yahoo Finance

Oct 01, 2026

International Business Machines Corp Stock (IBM) Opened Up by 4.68% on Oct 1: Key Drivers Unveiled - TradingKey

Oct 01, 2026

IBM Rises as New Self-Hosted AI Targets Regulated Firms - TradingPedia

Oct 01, 2026

IBM Stock Rises After Unveiling Self-Hosted Deployment for IBM Bob - Benzinga

Oct 01, 2026

Why is International Business Machines stock rallying today? - Investing.com

Oct 01, 2026

IBM's AI can help build software without moving sensitive code - Stock Titan

Oct 01, 2026

Sep 30, 2026

International Business Machines Corporation (IBM) Options Chain - Yahoo! Finance Canada

Sep 30, 2026

Only 6% of CFOs say AI is built into finance work and decisions at scale, IBM finds - Stock Titan

Sep 30, 2026

Artificial Intelligence (AI) in Life Sciences Market: Trends and Forecast to 2040 | Market to Reach USD 73.05 Billion at 20% CAGR as Drug Discovery and Precision Medicine Scale - GlobeNewswire Inc.

Sep 30, 2026

Sep 29, 2026